Background Usually the researchers performing meta-analysis of continuous outcomes
from clinical trials need their mean value and the variance (or standard deviation) in order to …

Objective To investigate whether funding of drug studies by the pharmaceutical industry is
associated with outcomes that are favourable to the funder and whether the methods of trials …

Description: Although approximately 85 million units of red blood cells (RBCs) are transfused
annually worldwide, transfusion practices vary widely. The AABB (formerly, the American …

The rationale was to develop recommendations on the use of 18 F-FDG PET in breast,
colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, …

Context The optimal treatment of acute myeloid leukemia (AML) in first complete remission (CR1)
is uncertain. Current consensus, based on cytogenetic risk, recommends …

Background: The AABB (formerly, the American Association of Blood Banks) developed this
guideline on appropriate use of platelet transfusion in adult patients. Methods: These …

Context The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin are
licensed to treat chemotherapy-associated anemia in patients with nonmyeloid malignancies. …

In response to limitations in the understanding and use of published evidence, evidence-based
medicine (EBM) began as a movement in the early 1990s. EBM's initial focus was on …

… Kahl, Benjamin Djulbegovic, Michael J. Robertson, Sven de Vos, Elliot Epner, Amrita Krishnan,
John P. Leonard, Sagar Lonial, Edward A. … Kahl, Benjamin Djulbegovic, Sven de Vos, Elliot …

This is an updated systematic review of 57 trials and 9353 cancer patients from articles,
abstracts, and reports published between January 1, 1985, and April 30, 2005, on the effects of …